X-3013190-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001011719.2(ARSH):c.340+18T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0016 in 1,195,217 control chromosomes in the GnomAD database, including 19 homozygotes. There are 511 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0084 ( 12 hom., 255 hem., cov: 22)
Exomes 𝑓: 0.00090 ( 7 hom. 256 hem. )
Consequence
ARSH
NM_001011719.2 intron
NM_001011719.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.122
Genes affected
ARSH (HGNC:32488): (arylsulfatase family member H) Sulfatases, such as ARSH, hydrolyze sulfate esters from sulfated steroids, carbohydrates, proteoglycans, and glycolipids. They are involved in hormone biosynthesis, modulation of cell signaling, and degradation of macromolecules (Sardiello et al., 2005 [PubMed 16174644]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant X-3013190-T-G is Benign according to our data. Variant chrX-3013190-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 558978.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00845 (941/111421) while in subpopulation AFR AF= 0.0296 (910/30722). AF 95% confidence interval is 0.028. There are 12 homozygotes in gnomad4. There are 255 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 12 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARSH | NM_001011719.2 | c.340+18T>G | intron_variant | ENST00000381130.3 | NP_001011719.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARSH | ENST00000381130.3 | c.340+18T>G | intron_variant | 1 | NM_001011719.2 | ENSP00000370522.3 |
Frequencies
GnomAD3 genomes AF: 0.00843 AC: 939AN: 111365Hom.: 12 Cov.: 22 AF XY: 0.00752 AC XY: 252AN XY: 33529
GnomAD3 genomes
AF:
AC:
939
AN:
111365
Hom.:
Cov.:
22
AF XY:
AC XY:
252
AN XY:
33529
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00259 AC: 424AN: 163669Hom.: 2 AF XY: 0.00179 AC XY: 90AN XY: 50415
GnomAD3 exomes
AF:
AC:
424
AN:
163669
Hom.:
AF XY:
AC XY:
90
AN XY:
50415
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000895 AC: 970AN: 1083796Hom.: 7 Cov.: 30 AF XY: 0.000729 AC XY: 256AN XY: 351010
GnomAD4 exome
AF:
AC:
970
AN:
1083796
Hom.:
Cov.:
30
AF XY:
AC XY:
256
AN XY:
351010
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00845 AC: 941AN: 111421Hom.: 12 Cov.: 22 AF XY: 0.00759 AC XY: 255AN XY: 33595
GnomAD4 genome
AF:
AC:
941
AN:
111421
Hom.:
Cov.:
22
AF XY:
AC XY:
255
AN XY:
33595
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Apr 25, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at